Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

Rong Fu Wang, Paul F. Robbins, Yutaka Kawakami, Xiao Qiang Kang, Steven A. Rosenberg

Research output: Contribution to journalArticle

264 Citations (Scopus)

Abstract

The availability of antitumor cytotoxic T lymphocytes which can be generated from either peripheral blood lymphocytes after stimulation in vitro or tumor infiltrating lymphocytes (TIL) has made it possible to identify a number of melanoma antigens presented by major histocompatibility complex class I molecules. The present and previous studies indicated that TIL586 recognized an antigen expressed on most melanoma and normal melanocytes in the context of the HLA-A31 molecule. We report here the cloning of a cDNA that directs the expression of the shared melanoma antigen recognized by this TIL. The DNA sequence analysis revealed that the cDNA was almost identical to the gene encoding tyrosinase-related protein 1 or glycoprotein gp75 which was originally identified by serum antibodies in a patient with melanoma. The gene was found to be expressed only in melanoma, normal melanocyte cell lines, and retina, but not in other normal tissues tested. The gp75 antigen presented by HLA-A31 may therefore constitute a useful immune target for specific treatment of patients with melanoma, since both antibody- and T cell mediated immune responses can be generated against this antigen.

Original languageEnglish
Pages (from-to)799-804
Number of pages6
JournalJournal of Experimental Medicine
Volume181
Issue number2
DOIs
Publication statusPublished - 1995 Feb 1
Externally publishedYes

Fingerprint

Melanoma-Specific Antigens
Tumor-Infiltrating Lymphocytes
Neoplasm Antigens
Melanoma
Melanocytes
Genes
Complementary DNA
Antigens
Antibodies
Cytotoxic T-Lymphocytes
Lymphocyte Activation
Major Histocompatibility Complex
DNA Sequence Analysis
Retina
Organism Cloning
Glycoproteins
T-Lymphocytes
Cell Line
HLA-A31 antigen
Serum

ASJC Scopus subject areas

  • Immunology

Cite this

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. / Wang, Rong Fu; Robbins, Paul F.; Kawakami, Yutaka; Kang, Xiao Qiang; Rosenberg, Steven A.

In: Journal of Experimental Medicine, Vol. 181, No. 2, 01.02.1995, p. 799-804.

Research output: Contribution to journalArticle

Wang, Rong Fu ; Robbins, Paul F. ; Kawakami, Yutaka ; Kang, Xiao Qiang ; Rosenberg, Steven A. / Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. In: Journal of Experimental Medicine. 1995 ; Vol. 181, No. 2. pp. 799-804.
@article{d3ec3df4fe1245e5b9ffedee0be2cfdd,
title = "Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes",
abstract = "The availability of antitumor cytotoxic T lymphocytes which can be generated from either peripheral blood lymphocytes after stimulation in vitro or tumor infiltrating lymphocytes (TIL) has made it possible to identify a number of melanoma antigens presented by major histocompatibility complex class I molecules. The present and previous studies indicated that TIL586 recognized an antigen expressed on most melanoma and normal melanocytes in the context of the HLA-A31 molecule. We report here the cloning of a cDNA that directs the expression of the shared melanoma antigen recognized by this TIL. The DNA sequence analysis revealed that the cDNA was almost identical to the gene encoding tyrosinase-related protein 1 or glycoprotein gp75 which was originally identified by serum antibodies in a patient with melanoma. The gene was found to be expressed only in melanoma, normal melanocyte cell lines, and retina, but not in other normal tissues tested. The gp75 antigen presented by HLA-A31 may therefore constitute a useful immune target for specific treatment of patients with melanoma, since both antibody- and T cell mediated immune responses can be generated against this antigen.",
author = "Wang, {Rong Fu} and Robbins, {Paul F.} and Yutaka Kawakami and Kang, {Xiao Qiang} and Rosenberg, {Steven A.}",
year = "1995",
month = "2",
day = "1",
doi = "10.1084/jem.181.2.799",
language = "English",
volume = "181",
pages = "799--804",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "2",

}

TY - JOUR

T1 - Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

AU - Wang, Rong Fu

AU - Robbins, Paul F.

AU - Kawakami, Yutaka

AU - Kang, Xiao Qiang

AU - Rosenberg, Steven A.

PY - 1995/2/1

Y1 - 1995/2/1

N2 - The availability of antitumor cytotoxic T lymphocytes which can be generated from either peripheral blood lymphocytes after stimulation in vitro or tumor infiltrating lymphocytes (TIL) has made it possible to identify a number of melanoma antigens presented by major histocompatibility complex class I molecules. The present and previous studies indicated that TIL586 recognized an antigen expressed on most melanoma and normal melanocytes in the context of the HLA-A31 molecule. We report here the cloning of a cDNA that directs the expression of the shared melanoma antigen recognized by this TIL. The DNA sequence analysis revealed that the cDNA was almost identical to the gene encoding tyrosinase-related protein 1 or glycoprotein gp75 which was originally identified by serum antibodies in a patient with melanoma. The gene was found to be expressed only in melanoma, normal melanocyte cell lines, and retina, but not in other normal tissues tested. The gp75 antigen presented by HLA-A31 may therefore constitute a useful immune target for specific treatment of patients with melanoma, since both antibody- and T cell mediated immune responses can be generated against this antigen.

AB - The availability of antitumor cytotoxic T lymphocytes which can be generated from either peripheral blood lymphocytes after stimulation in vitro or tumor infiltrating lymphocytes (TIL) has made it possible to identify a number of melanoma antigens presented by major histocompatibility complex class I molecules. The present and previous studies indicated that TIL586 recognized an antigen expressed on most melanoma and normal melanocytes in the context of the HLA-A31 molecule. We report here the cloning of a cDNA that directs the expression of the shared melanoma antigen recognized by this TIL. The DNA sequence analysis revealed that the cDNA was almost identical to the gene encoding tyrosinase-related protein 1 or glycoprotein gp75 which was originally identified by serum antibodies in a patient with melanoma. The gene was found to be expressed only in melanoma, normal melanocyte cell lines, and retina, but not in other normal tissues tested. The gp75 antigen presented by HLA-A31 may therefore constitute a useful immune target for specific treatment of patients with melanoma, since both antibody- and T cell mediated immune responses can be generated against this antigen.

UR - http://www.scopus.com/inward/record.url?scp=0028906594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028906594&partnerID=8YFLogxK

U2 - 10.1084/jem.181.2.799

DO - 10.1084/jem.181.2.799

M3 - Article

C2 - 7836932

AN - SCOPUS:0028906594

VL - 181

SP - 799

EP - 804

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 2

ER -